Cargando…

OR25-4 Modulatory Effects of Estradiol on the Resting-State Functional Connectivity in Transwomen Following Gender Affirming Surgery

The profound incongruence between sex and gender identity leads transgender individuals to seek cross-sex hormone therapy (CSHT) and gender affirming surgery (GAS). After GAS, a transient period of hypogonadism is established. Literature suggests that sex hormones exert important effects on the brai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schneider, Maiko, Spritzer, Poli, Minuzzi, Luciano, Frey, Benício, Fighera, Tayane Muniz, Syan, Sabrina, Lobato, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554921/ http://dx.doi.org/10.1210/js.2019-OR25-4

Ejemplares similares

Effects of Estradiol Therapy on Resting-State Functional Connectivity of Transgender Women After Gender-Affirming Related Gonadectomy
por: Schneider, Maiko A., et al.
Publicado: (2019)

Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
por: Da Silva, Eliane Dias, et al.
Publicado: (2021)

SAT382 Lean Mass and Associated Factors in Women with PCOS with Different Phenotypes
por: Fighera, Tayane Muniz, et al.
Publicado: (2023)

MON-393 Evaluation of Bone Mass in Transgender Women After Gender Affirming Surgery - a Pilot Study
por: Fighera, Tayane Muniz, et al.
Publicado: (2020)

Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy
por: Silva, Eliane D., et al.
Publicado: (2021)

Effect of Intranasal Calcitonin in a Patient with McCune-Albright Syndrome, Fibrous Dysplasia, and Refractory Bone Pain
por: Fighera, Tayane Muniz, et al.
Publicado: (2017)

Lean mass and associated factors in women with PCOS with different phenotypes
por: Fighera, Tayane Muniz, et al.
Publicado: (2023)

SUN-534 Effect of Cross-Sex Hormone Therapy on Body Composition, Visceral Adipose Tissue, and Bone Mineral Density in Transgender Men
por: Fighera, Tayane, et al.
Publicado: (2019)

From anatomy to function: the role of the somatosensory cortex in emotional regulation
por: Kropf, Erika, et al.
Publicado: (2018)

Hirsutism, Normal Androgens and Diagnosis of PCOS
por: Spritzer, Poli Mara, et al.
Publicado: (2022)

Bone Mass Effects of Cross-Sex Hormone Therapy in Transgender People: Updated Systematic Review and Meta-Analysis
por: Fighera, Tayane Muniz, et al.
Publicado: (2019)

Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen
por: Scheres, Luuk J.J., et al.
Publicado: (2021)

RF34 | PMON276 The Effect of Gender Affirming Hormone Therapy (GAHT) on Non-Conventional Cardiovascular Risk Markers in Transgender Men: A Systematic Review
por: Moreira Allgayer, Roberta Martins Costa, et al.
Publicado: (2022)

Gender‐Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen
por: Vlot, Mariska C, et al.
Publicado: (2019)

A DSM-5-based tool to monitor concurrent mood and premenstrual symptoms: the McMaster Premenstrual and Mood Symptom Scale (MAC-PMSS)
por: Frey, Benicio N., et al.
Publicado: (2022)

RF06 | PSAT152 Associations between Bone Mass, Hormone Levels and Body Composition in Postmenopausal Women
por: Fighera, Tayane, et al.
Publicado: (2022)

Bone Safety During the First Ten Years of Gender‐Affirming Hormonal Treatment in Transwomen and Transmen
por: Wiepjes, Chantal M, et al.
Publicado: (2018)

Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma
por: Zanella, André Borsatto, et al.
Publicado: (2022)

THU256 Prevalence And Risk Factors Associated With Diabetes Mellitus Among Middle Aged Women In Southern Brazil: A Population Based Study
por: Oppermann, Karen, et al.
Publicado: (2023)

SUN-044 Gonadotropin Releasing Hormone (GnRH) Agonist Therapy Induces a Sustained Reduction in Plasma Testosterone Levels and Is Well Tolerated in Transwomen Veterans
por: Gondin, Lyan, et al.
Publicado: (2020)

Brain Structure and Function in Women with Comorbid Bipolar and Premenstrual Dysphoric Disorder
por: Syan, Sabrina K., et al.
Publicado: (2018)

SAT409 Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study
por: Yaish, Iris, et al.
Publicado: (2023)

SAT379 Potassium Levels in Women with PCOS Using Spironolactone for Long-term
por: Oliveira, Thais Areias, et al.
Publicado: (2023)

SUN-013 Cardiometabolic Profile of Brazilian Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review and Meta-Analysis
por: Marchesan, Lucas Bandeira, et al.
Publicado: (2020)

Estradiol-driven metabolism in transwomen associates with reduced circulating extracellular vesicle microRNA-224/452
por: Florijn, Barend W, et al.
Publicado: (2021)

Effect on Kidney Function During Gender Affirming Hormonal Treatment in Transgender Individuals
por: Maheshwari, Arvind Kumar, et al.
Publicado: (2021)

Prolactinoma in a Male to Female Transgender Woman on Gender Affirming Hormone Therapy
por: Harned, Leighton K, et al.
Publicado: (2021)

SAT-234 DBP Gene Polymorphisms in Adult and Postmenopausal Women: Association with DBP and Vitamin D Serum Levels
por: Santos, Betânia, et al.
Publicado: (2019)

Achieving Physiologic 17-ẞ-Estradiol Levels in Transgender Females on Estradiol Transdermal Patches and Optimal Dosing
por: Trovato, Alexa, et al.
Publicado: (2021)

Comorbid Premenstrual Dysphoric Disorder and Bipolar Disorder: A Review
por: Slyepchenko, Anastasiya, et al.
Publicado: (2021)

Assessment of Estradiol-Induced Gonadotropin Surge Generation: Preliminary Results From a Protocol of Graded Transdermal Estradiol Dosing
por: McCartney, Christopher R, et al.
Publicado: (2021)

PMON246 Prevalence of Hypertension and Metabolic Syndrome in Women with PCOS from France and Brazil
por: Spritzer, Poli Mara, et al.
Publicado: (2022)

ODP414 Incidence of Suicidal Events in Transgender Patients with Initiation of Gender Affirming Hormone Therapy
por: Elliott, Karma-Jaya, et al.
Publicado: (2022)

Sexual & reproductive health information on minor consent forms for pubertal suppression and gender affirming hormones
por: Taylor, Julia, et al.
Publicado: (2023)

SAT422 Gender Affirming Hormone Therapy in a Non-Binary Individual with Swyer Syndrome
por: Yohannan, Jiby M, et al.
Publicado: (2023)

MON-195 Trans-transgender Female: Gender Identity Reversal Following Irreversible Gender Affirming Surgeries
por: Korpaisarn, Sira, et al.
Publicado: (2019)

SUN-039 Estradiol Dose and Concentrations in Transfeminine Individuals
por: Nolan, Brendan J, et al.
Publicado: (2020)

Are Vitamin D Deficiency and VDR Gene Polymorphisms Associated With Higher Blood Pressure Defined by the 2017 ACC/AHA in Postmenopausal Women?
por: dos Santos, Betânia Rodrigues, et al.
Publicado: (2021)

MON-196 Gender-Affirming Hormonal Therapy and Incidence of Metabolic Syndrome and Cardiovascular Events in Patients with Gender Dysphoria
por: Mok, Mary, et al.
Publicado: (2019)

PMON280 Effect of Gender Affirming Hormone Therapy (GAHT) on Adipose Tissue Morphology and Metabolism in Transgender Individuals
por: Shah, Manasi S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kpki4m62tu7pnjp6sl6i9hub7v